In Treatment of Bacterial infections Proxecef 30mg Tablet DT works by killing the infection-causing bacteria in your body. It is effective for bacterial infections of the lungs, throat, and urinary tract among others. This medicine usually makes you feel better within a few days, but you should continue taking it as prescribed even when you feel better. Stopping it early may make the infection come back and harder to treat.
Consuming alcohol with Proxecef 30mg Tablet DT does not cause any harmful side effects.
Proxecef 30mg Tablet DT is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Proxecef 30mg Tablet DT is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby. Avoid prolonged use of Proxecef 30mg Tablet DT, since it may have possible effects such as rash and diarrhea.
Proxecef 30mg Tablet DT may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Proxecef 30mg Tablet DT should be used with caution in patients with kidney disease. Dose adjustment of Proxecef 30mg Tablet DT may be needed. Please consult your doctor.
Proxecef 30mg Tablet DT should be used with caution in patients with severe liver disease. Dose adjustment of Proxecef 30mg Tablet DT may be needed. Please consult your doctor. Limited information is available on use of Proxecef 30mg Tablet DT in patients with severe liver disease.
If you miss a dose of Proxecef 30mg Tablet DT, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More